MedPath

Effects of Plant Based Lipids on Glucose Regulation and Cognitive Variables

Not Applicable
Completed
Conditions
Obesity
Diabete Type 2
Interventions
Dietary Supplement: lipids
Registration Number
NCT05276128
Lead Sponsor
Lund University
Brief Summary

The overall goal is to increase the knowledge that can be used for the development of food products with anti-diabetic properties, with the purpose to facilitate healthier food choices for people. More specifically the primary purpose of this project is to evaluate effects in healthy humans on acute postprandial glucose regulation of plant based lipids. Due to the tight connection between cardiometabolic health and cognitive functions, a secondary issue is to investigate effects of test foods on cognitive test variables and mood parameters.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • Apparently healthy subjects
  • Between 20 and 40 years old
  • Body mass index between 19-28 kg / m2),
  • Consuming a non-vegetarian diet generally in line with the Nordic nutrition recommendations.
Exclusion Criteria
  • Fasting blood glucose concentration >6.1 mmol/L
  • Known metabolic or gastrointestinal disorder (eg diabetes, high cholesterol, high blood pressure, IBS), or other disease that may affect the study results.
  • Regular medication, except for long-term and stable medication for the lack or reduced production of thyroid hormone (eg Levaxin).
  • Antibiotics or probiotics for at least four weeks before the start of the study,
  • The use of tobacco products

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
WWB ReferencelipidsWhite wheat bread (WWB) without lipid supplements. The effects of this high glycaemic product on postprandial glucose and insulin responses are well studied.
WWB 10g active lipidslipidsWWB supplemented with 10g active lipids, and 5 g control lipids
WWB 5g active lipidslipidsWWB supplemented with 5 g active lipids, and 10 g control lipids
WWB 15g active lipidslipidsWWB supplemented with 15g active lipids, and 0 g control lipids
WWB 15 g control lipidslipidsWWB supplemented with 15g control lipids
Primary Outcome Measures
NameTimeMethod
glucose tolerance3 hours. Fasting (time =0), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutes

Postprandial blood glucose responses

Secondary Outcome Measures
NameTimeMethod
Insulin responses3 hours. Fasting (time =0 minutes), 30 minutes, 45 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutes

Postprandial insulin responses

Mood variables60 minutes after start of test product, after 120 minutes and after 180 minutes

Registration of subjective mood ratings (valence and activity) on 0-100 mm Visual Analogue Scales (VAS) at fasting and thereafter every hour until 180 min. Extremes of the sensations of the variables is at the two ends of the scales, i.e. 0 mm relates to the extrem of low senations sensations and 100 mm correspond to the highest sensation of the variables.

Appetite sensations3 hours. Fasting (time =0), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutes

Subjective sensations of hunger, satiety, and desire to eat are registered on 0-100 mm VAS scales. Extremes of the sensations of the variables is at the two ends of the scales, i.e. 0 mm relates to the extrem of low senations sensations and 100 mm correspond to the highest sensation of the variables.

Trial Locations

Locations (2)

Anne Nilsson

🇸🇪

Lund, Välj..., Sweden

The Human Trial Facility, Food Technology engineering and Nutrition, Lund University

🇸🇪

Lund, Välj..., Sweden

© Copyright 2025. All Rights Reserved by MedPath